Dr. Karin Bok is the VRC’s Acting Deputy Director and Director of Pandemic Preparedness and Emergency Response. In addition to contributing to the leadership of the scientific and clinical research activities of the VRC, she provides scientific expertise for the development of several preparedness and response medical countermeasures, including preventive and therapeutic products against Ebola, Zika, Nipah, influenza, and coronavirus. Dr. Bok collaborates with government colleagues and external stakeholders to prepare and accelerate the response to an infectious disease emergency and advance the study of preventive measures that target unmet medical needs. She currently holds a leading role in H-CORE (HHS Coordination Operations and Response Element, former Operation Warp Speed) contributing to accelerating the development and testing of vaccines against SARS-CoV-2 in the U.S. She is also part of a senior team working on the advanced development of broadly neutralizing monoclonal antibodies for HIV, as well as universal influenza and RSV vaccines. In addition, Dr. Bok has more than 20 years of experience working on research and discovery programs, leading her own scientific studies focused on vaccines, antibody products, antivirals, diagnostics, and viral evolution of gastrointestinal viruses.